ÇAĞAN, M. Et Al. 2022. Singleton pregnancy losses before gestational week 22 among patients with autoimmune disorders and methylenetetrahydrofolate reductase polymorphisms. Human Antibodies , vol.30, no.2 , 59-65.

ÇAĞAN, M., Okuducu, U., DÖNMEZ, H. G., & Beksac, M. S., (2022). Singleton pregnancy losses before gestational week 22 among patients with autoimmune disorders and methylenetetrahydrofolate reductase polymorphisms. Human Antibodies , vol.30, no.2, 59-65.

ÇAĞAN, MURAT Et Al. "Singleton pregnancy losses before gestational week 22 among patients with autoimmune disorders and methylenetetrahydrofolate reductase polymorphisms," Human Antibodies , vol.30, no.2, 59-65, 2022

ÇAĞAN, MURAT Et Al. "Singleton pregnancy losses before gestational week 22 among patients with autoimmune disorders and methylenetetrahydrofolate reductase polymorphisms." Human Antibodies , vol.30, no.2, pp.59-65, 2022

ÇAĞAN, M. Et Al. (2022) . "Singleton pregnancy losses before gestational week 22 among patients with autoimmune disorders and methylenetetrahydrofolate reductase polymorphisms." Human Antibodies , vol.30, no.2, pp.59-65.

@article{article, author={MURAT ÇAĞAN Et Al. }, title={Singleton pregnancy losses before gestational week 22 among patients with autoimmune disorders and methylenetetrahydrofolate reductase polymorphisms}, journal={Human Antibodies}, year=2022, pages={59-65} }